These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1425 related items for PubMed ID: 12421111

  • 21. Etanercept (Enbrel): update on therapeutic use.
    Spencer-Green G.
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i46-9. PubMed ID: 11053088
    [Abstract] [Full Text] [Related]

  • 22. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
    van der Heijde D, Klareskog L, Landewé R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S.
    Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208
    [Abstract] [Full Text] [Related]

  • 23. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
    Cole P, Rabasseda X.
    Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
    [Abstract] [Full Text] [Related]

  • 24. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
    Schiff MH, Yu EB, Weinblatt ME, Moreland LW, Genovese MC, White B, Singh A, Chon Y, Woolley JM.
    Drugs Aging; 2006 Apr; 23(2):167-78. PubMed ID: 16536638
    [Abstract] [Full Text] [Related]

  • 25. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
    Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME.
    Ann Intern Med; 1999 Mar 16; 130(6):478-86. PubMed ID: 10075615
    [Abstract] [Full Text] [Related]

  • 26. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
    Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK.
    N Engl J Med; 2000 Mar 16; 342(11):763-9. PubMed ID: 10717011
    [Abstract] [Full Text] [Related]

  • 27. Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial.
    Mease PJ, Gladman DD, Collier DH, Ritchlin CT, Helliwell PS, Liu L, Kricorian G, Chung JB.
    Arthritis Rheumatol; 2019 Jul 16; 71(7):1112-1124. PubMed ID: 30747501
    [Abstract] [Full Text] [Related]

  • 28. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
    Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK.
    N Engl J Med; 2000 Nov 30; 343(22):1586-93. PubMed ID: 11096165
    [Abstract] [Full Text] [Related]

  • 29. Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study.
    Kameda H, Kanbe K, Sato E, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Yamanaka H, Takeuchi T.
    J Rheumatol; 2011 Aug 30; 38(8):1585-92. PubMed ID: 21572151
    [Abstract] [Full Text] [Related]

  • 30. Spotlight on etanercept in plaque psoriasis and psoriatic arthritis.
    Goldsmith DR, Wagstaff AJ.
    BioDrugs; 2005 Aug 30; 19(6):401-3. PubMed ID: 16392892
    [Abstract] [Full Text] [Related]

  • 31. Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
    Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Kurosawa R, Kawano Y, Yokota S, Sugiyama N, Yuasa H, Fletcher T, Wajdula JS.
    Mod Rheumatol; 2011 Dec 30; 21(6):572-8. PubMed ID: 21479889
    [Abstract] [Full Text] [Related]

  • 32. Etanercept: new preparation. Useful after methotrexate failure in inflammatory rheumatism.
    Prescrire Int; 2003 Aug 30; 12(66):127-32. PubMed ID: 12906020
    [Abstract] [Full Text] [Related]

  • 33. Etanercept for the treatment of rheumatoid arthritis.
    Blumenauer B, Judd M, Cranney A, Burls A, Coyle D, Hochberg M, Tugwell P, Wells G.
    Cochrane Database Syst Rev; 2003 Aug 30; (4):CD004525. PubMed ID: 14584021
    [Abstract] [Full Text] [Related]

  • 34. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ.
    Arthritis Rheum; 2004 Feb 30; 50(2):353-63. PubMed ID: 14872476
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.
    Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kümmerle-Deschner JB, Tenbrock K, Ganser G, Huppertz HI.
    Arthritis Rheumatol; 2015 May 30; 67(8):2240-9. PubMed ID: 25891010
    [Abstract] [Full Text] [Related]

  • 36. Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis.
    Tanno M, Nakamura I, Ito K, Tanaka H, Ohta H, Kobayashi M, Tachihara A, Nagashima M, Yoshino S, Nakajima A.
    Mod Rheumatol; 2006 May 30; 16(2):77-84. PubMed ID: 16633926
    [Abstract] [Full Text] [Related]

  • 37. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B.
    J Rheumatol; 2006 Feb 30; 33(2):234-43. PubMed ID: 16465653
    [Abstract] [Full Text] [Related]

  • 38. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA, Guzman RM, Xavier RM, Simon JA, Mele L, Pedersen R, Ferdousi T, Koenig AS, Kotak S, Vlahos B.
    J Clin Rheumatol; 2014 Jan 30; 20(1):25-33. PubMed ID: 24356474
    [Abstract] [Full Text] [Related]

  • 39. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
    van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, Tornero-Molina J, Wajdula J, Pedersen R, Fatenejad S, TEMPO Study Investigators.
    Arthritis Rheum; 2006 Apr 30; 54(4):1063-74. PubMed ID: 16572441
    [Abstract] [Full Text] [Related]

  • 40. Etanercept in psoriatic arthritis.
    Spadaro A, Lubrano E, Ferrara N, Scarpa R.
    J Rheumatol Suppl; 2012 Jul 30; 89():74-6. PubMed ID: 22751599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 72.